Survival after reduced-size liver transplantation is dependent on pretransplant status

R. Bilik, P. Greig, B. Langer, R. A. Superina*

*Corresponding author for this work

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Orthotopic liver transplantation (OLT) in children is characterized by unique problems including a shortage of compatible-size donors resulting in long waiting periods, significant deterioration while waiting, and death before transplantation. To improve the chances of obtaining an organ for the sickest patients, reduced-size liver transplantation (RSLT) was offered to all hospital-bound children starting in July 1988. Since then, 68 OLTs were performed in 58 children. Thirty-six RSLTs were done in 30 children (42% of total 86 OLT, 53% since 1988). The mean weight of the RSLT patients was 13.5±10.4 kg versus 23.8±21.9 kg in the full-size (FSLT) group (P<.05). Twenty-five of 39 transplants (71.4%) done in children<10 kg were RSLTs in comparison to only 10 of 47 (21.3%) in patients>10 kg (P<.0005). Since 1988, 25 of 34 (73.5%) of all transplants in children<10 kg have been RSLTs. Average donor to recipient weight ratio in the RSLT group was 4.21:1 versus 1.17:1 in the FSLT group (P<.0001). RSLT was done as a primary procedure in 26 patients and as a retransplant in 10. Mean blood product replacement was significantly higher in the RSLT group both intraoperatively (515.7±490.9 v 177.2±278.3 mL/kg, P<.005) and during the first 24 hours postoperation (50.5±81.8 mL/kg v 16.4±28.5 mL/kg, P<.05). Primary graft nonfunction was lower in the RSLT group (9.1% in RSLT, 14% in the FSLT group, P=NS) despite longer cold ischemia times (10.2±2.8 v 8.5±3.1 hours, P<.05) in RSLT. Arterial thrombosis rate was 7.8% in FSLT and 11.4% in RSLT (NS). Postoperative bleeding requiring reoperation, bile leak, hematoma, and intraabdominal abscess were more frequent in the RSLT group (54.7% v 30%, P>.05). Survival rate of stable patients (status 1 and 2) was similar whether they received a RSLT or a FSLT first (73.3 v 79.0, P>.05). Survival for ICU patients (status 3 and 4) was similar whether a reduced or full size graft was used first (50% v 80%, P>.05). Mortality on the waiting list decreased from 29.2% to 5.6% (P<.05) since RSLTs were started. Only 1 out of 10 patients who received RSLTs as secondary procedures survived (11.1%). Deaths occured from 1 to 48 days following the second transplant (mean, 21.4±21.6 days), and causes of death included severe cytomegalovirus sepsis (2), myocardial infarction (1), bacterial sepsis (3), multiorgan failure (3), and primary nonfunction (1). Only one of the deaths was attributable to failure of the reduced-size graft to function. We conclude that primary elective RSLT results in equally good survival as FSLT and significantly reduces mortality on the waiting list with only minimal additional morbidity. Our policy at the present time is to offer early RSLT to all children on the waiting list.

Original languageEnglish (US)
Pages (from-to)1307-1311
Number of pages5
JournalJournal of Pediatric Surgery
Volume28
Issue number10
DOIs
StatePublished - Jan 1 1993

Fingerprint

Liver Transplantation
Survival
Waiting Lists
Transplants
Sepsis
Mortality
Cytomegalovirus
Cause of Death
Survival Rate
Transplantation
Myocardial Infarction
Tissue Donors
Morbidity
Weights and Measures

Keywords

  • Liver transplantation
  • reduced-size liver grafts

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Surgery

Cite this

@article{8b5c2ee174ab4f458110c5f80823b015,
title = "Survival after reduced-size liver transplantation is dependent on pretransplant status",
abstract = "Orthotopic liver transplantation (OLT) in children is characterized by unique problems including a shortage of compatible-size donors resulting in long waiting periods, significant deterioration while waiting, and death before transplantation. To improve the chances of obtaining an organ for the sickest patients, reduced-size liver transplantation (RSLT) was offered to all hospital-bound children starting in July 1988. Since then, 68 OLTs were performed in 58 children. Thirty-six RSLTs were done in 30 children (42{\%} of total 86 OLT, 53{\%} since 1988). The mean weight of the RSLT patients was 13.5±10.4 kg versus 23.8±21.9 kg in the full-size (FSLT) group (P<.05). Twenty-five of 39 transplants (71.4{\%}) done in children<10 kg were RSLTs in comparison to only 10 of 47 (21.3{\%}) in patients>10 kg (P<.0005). Since 1988, 25 of 34 (73.5{\%}) of all transplants in children<10 kg have been RSLTs. Average donor to recipient weight ratio in the RSLT group was 4.21:1 versus 1.17:1 in the FSLT group (P<.0001). RSLT was done as a primary procedure in 26 patients and as a retransplant in 10. Mean blood product replacement was significantly higher in the RSLT group both intraoperatively (515.7±490.9 v 177.2±278.3 mL/kg, P<.005) and during the first 24 hours postoperation (50.5±81.8 mL/kg v 16.4±28.5 mL/kg, P<.05). Primary graft nonfunction was lower in the RSLT group (9.1{\%} in RSLT, 14{\%} in the FSLT group, P=NS) despite longer cold ischemia times (10.2±2.8 v 8.5±3.1 hours, P<.05) in RSLT. Arterial thrombosis rate was 7.8{\%} in FSLT and 11.4{\%} in RSLT (NS). Postoperative bleeding requiring reoperation, bile leak, hematoma, and intraabdominal abscess were more frequent in the RSLT group (54.7{\%} v 30{\%}, P>.05). Survival rate of stable patients (status 1 and 2) was similar whether they received a RSLT or a FSLT first (73.3 v 79.0, P>.05). Survival for ICU patients (status 3 and 4) was similar whether a reduced or full size graft was used first (50{\%} v 80{\%}, P>.05). Mortality on the waiting list decreased from 29.2{\%} to 5.6{\%} (P<.05) since RSLTs were started. Only 1 out of 10 patients who received RSLTs as secondary procedures survived (11.1{\%}). Deaths occured from 1 to 48 days following the second transplant (mean, 21.4±21.6 days), and causes of death included severe cytomegalovirus sepsis (2), myocardial infarction (1), bacterial sepsis (3), multiorgan failure (3), and primary nonfunction (1). Only one of the deaths was attributable to failure of the reduced-size graft to function. We conclude that primary elective RSLT results in equally good survival as FSLT and significantly reduces mortality on the waiting list with only minimal additional morbidity. Our policy at the present time is to offer early RSLT to all children on the waiting list.",
keywords = "Liver transplantation, reduced-size liver grafts",
author = "R. Bilik and P. Greig and B. Langer and Superina, {R. A.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1016/S0022-3468(05)80318-5",
language = "English (US)",
volume = "28",
pages = "1307--1311",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "10",

}

Survival after reduced-size liver transplantation is dependent on pretransplant status. / Bilik, R.; Greig, P.; Langer, B.; Superina, R. A.

In: Journal of Pediatric Surgery, Vol. 28, No. 10, 01.01.1993, p. 1307-1311.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Survival after reduced-size liver transplantation is dependent on pretransplant status

AU - Bilik, R.

AU - Greig, P.

AU - Langer, B.

AU - Superina, R. A.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Orthotopic liver transplantation (OLT) in children is characterized by unique problems including a shortage of compatible-size donors resulting in long waiting periods, significant deterioration while waiting, and death before transplantation. To improve the chances of obtaining an organ for the sickest patients, reduced-size liver transplantation (RSLT) was offered to all hospital-bound children starting in July 1988. Since then, 68 OLTs were performed in 58 children. Thirty-six RSLTs were done in 30 children (42% of total 86 OLT, 53% since 1988). The mean weight of the RSLT patients was 13.5±10.4 kg versus 23.8±21.9 kg in the full-size (FSLT) group (P<.05). Twenty-five of 39 transplants (71.4%) done in children<10 kg were RSLTs in comparison to only 10 of 47 (21.3%) in patients>10 kg (P<.0005). Since 1988, 25 of 34 (73.5%) of all transplants in children<10 kg have been RSLTs. Average donor to recipient weight ratio in the RSLT group was 4.21:1 versus 1.17:1 in the FSLT group (P<.0001). RSLT was done as a primary procedure in 26 patients and as a retransplant in 10. Mean blood product replacement was significantly higher in the RSLT group both intraoperatively (515.7±490.9 v 177.2±278.3 mL/kg, P<.005) and during the first 24 hours postoperation (50.5±81.8 mL/kg v 16.4±28.5 mL/kg, P<.05). Primary graft nonfunction was lower in the RSLT group (9.1% in RSLT, 14% in the FSLT group, P=NS) despite longer cold ischemia times (10.2±2.8 v 8.5±3.1 hours, P<.05) in RSLT. Arterial thrombosis rate was 7.8% in FSLT and 11.4% in RSLT (NS). Postoperative bleeding requiring reoperation, bile leak, hematoma, and intraabdominal abscess were more frequent in the RSLT group (54.7% v 30%, P>.05). Survival rate of stable patients (status 1 and 2) was similar whether they received a RSLT or a FSLT first (73.3 v 79.0, P>.05). Survival for ICU patients (status 3 and 4) was similar whether a reduced or full size graft was used first (50% v 80%, P>.05). Mortality on the waiting list decreased from 29.2% to 5.6% (P<.05) since RSLTs were started. Only 1 out of 10 patients who received RSLTs as secondary procedures survived (11.1%). Deaths occured from 1 to 48 days following the second transplant (mean, 21.4±21.6 days), and causes of death included severe cytomegalovirus sepsis (2), myocardial infarction (1), bacterial sepsis (3), multiorgan failure (3), and primary nonfunction (1). Only one of the deaths was attributable to failure of the reduced-size graft to function. We conclude that primary elective RSLT results in equally good survival as FSLT and significantly reduces mortality on the waiting list with only minimal additional morbidity. Our policy at the present time is to offer early RSLT to all children on the waiting list.

AB - Orthotopic liver transplantation (OLT) in children is characterized by unique problems including a shortage of compatible-size donors resulting in long waiting periods, significant deterioration while waiting, and death before transplantation. To improve the chances of obtaining an organ for the sickest patients, reduced-size liver transplantation (RSLT) was offered to all hospital-bound children starting in July 1988. Since then, 68 OLTs were performed in 58 children. Thirty-six RSLTs were done in 30 children (42% of total 86 OLT, 53% since 1988). The mean weight of the RSLT patients was 13.5±10.4 kg versus 23.8±21.9 kg in the full-size (FSLT) group (P<.05). Twenty-five of 39 transplants (71.4%) done in children<10 kg were RSLTs in comparison to only 10 of 47 (21.3%) in patients>10 kg (P<.0005). Since 1988, 25 of 34 (73.5%) of all transplants in children<10 kg have been RSLTs. Average donor to recipient weight ratio in the RSLT group was 4.21:1 versus 1.17:1 in the FSLT group (P<.0001). RSLT was done as a primary procedure in 26 patients and as a retransplant in 10. Mean blood product replacement was significantly higher in the RSLT group both intraoperatively (515.7±490.9 v 177.2±278.3 mL/kg, P<.005) and during the first 24 hours postoperation (50.5±81.8 mL/kg v 16.4±28.5 mL/kg, P<.05). Primary graft nonfunction was lower in the RSLT group (9.1% in RSLT, 14% in the FSLT group, P=NS) despite longer cold ischemia times (10.2±2.8 v 8.5±3.1 hours, P<.05) in RSLT. Arterial thrombosis rate was 7.8% in FSLT and 11.4% in RSLT (NS). Postoperative bleeding requiring reoperation, bile leak, hematoma, and intraabdominal abscess were more frequent in the RSLT group (54.7% v 30%, P>.05). Survival rate of stable patients (status 1 and 2) was similar whether they received a RSLT or a FSLT first (73.3 v 79.0, P>.05). Survival for ICU patients (status 3 and 4) was similar whether a reduced or full size graft was used first (50% v 80%, P>.05). Mortality on the waiting list decreased from 29.2% to 5.6% (P<.05) since RSLTs were started. Only 1 out of 10 patients who received RSLTs as secondary procedures survived (11.1%). Deaths occured from 1 to 48 days following the second transplant (mean, 21.4±21.6 days), and causes of death included severe cytomegalovirus sepsis (2), myocardial infarction (1), bacterial sepsis (3), multiorgan failure (3), and primary nonfunction (1). Only one of the deaths was attributable to failure of the reduced-size graft to function. We conclude that primary elective RSLT results in equally good survival as FSLT and significantly reduces mortality on the waiting list with only minimal additional morbidity. Our policy at the present time is to offer early RSLT to all children on the waiting list.

KW - Liver transplantation

KW - reduced-size liver grafts

UR - http://www.scopus.com/inward/record.url?scp=0027437921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027437921&partnerID=8YFLogxK

U2 - 10.1016/S0022-3468(05)80318-5

DO - 10.1016/S0022-3468(05)80318-5

M3 - Article

C2 - 8263692

AN - SCOPUS:0027437921

VL - 28

SP - 1307

EP - 1311

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 10

ER -